CD19 and Bruton-type agammaglobulinemia: As previously shown,39 the xenograft model did not faithfully recapitulate the phenotype observed in patients with XLA, but displayed an abrogated phenotype with CD34−/CD19+ cells (cells at the pre–B-cell stage and onward) present in the bone marrow of XLA transplanted mice.